These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21987440)

  • 21. Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection.
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Dec; 45(12):1281-328. PubMed ID: 18080231
    [No Abstract]   [Full Text] [Related]  

  • 22. A "sandwich" strategy for functional cure of chronic hepatitis B.
    Wang XY; Wen YM
    Emerg Microbes Infect; 2018 May; 7(1):91. PubMed ID: 29769522
    [No Abstract]   [Full Text] [Related]  

  • 23. HBsAg clearance by Peg-interferon addition to a long-term nucleos(t)ide analogue therapy.
    Barone M; Iannone A; Di Leo A
    World J Gastroenterol; 2014 Jul; 20(26):8722-5. PubMed ID: 25024631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, incidence, and clinical relevance of the reverse transcriptase V207I mutation outside the YMDD motif of the hepatitis B virus polymerase during lamivudine therapy.
    Zöllner B; Sterneck M; Wursthorn K; Petersen J; Schröter M; Laufs R; Feucht HH
    J Clin Microbiol; 2005 May; 43(5):2503-5. PubMed ID: 15872296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
    Bourlière M; Rabiega P; Ganne-Carrie N; Serfaty L; Marcellin P; Barthe Y; Thabut D; Guyader D; Hezode C; Picon M; Causse X; Leroy V; Bronowicki JP; Carrieri P; Riachi G; Rosa I; Attali P; Molina JM; Bacq Y; Tran A; Grangé JD; Zoulim F; Fontaine H; Alric L; Bertucci I; Bouvier-Alias M; Carrat F;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):177-188. PubMed ID: 28404133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives on dual hepatitis B and C infection in Taiwan.
    Liu CJ; Chen PJ; Chen DS; Tseng TC; Kao JH
    J Formos Med Assoc; 2016 May; 115(5):298-305. PubMed ID: 26188762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: on-treatment kinetics of HBsAg serum levels vary by HBV genotype.
    Brunetto MR; Marcellin P; Cherubini B; Yurdaydin C; Farci P; Hadziyannis SJ; Rothe V; Regep L; Bonino F
    J Hepatol; 2013 Dec; 59(6):1153-9. PubMed ID: 23872601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?
    Janssen HL; Sonneveld MJ; Brunetto MR
    Gut; 2012 May; 61(5):641-5. PubMed ID: 22180061
    [No Abstract]   [Full Text] [Related]  

  • 29. Current management of delta hepatitis.
    Rizzetto M
    Liver Int; 2013 Feb; 33 Suppl 1():195-7. PubMed ID: 23286865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy.
    Lutterkort GL; Wranke A; Hengst J; Yurdaydin C; Stift J; Bremer B; Hardtke S; Keskin O; Idilman R; Manns MP; Dienes HP; Falk C; Wedemeyer H; Heidrich B
    J Viral Hepat; 2018 Nov; 25(11):1384-1394. PubMed ID: 29888837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-alpha 2b improves short-term survival in patients transplanted for chronic liver failure caused by hepatitis B.
    Hassanein T; Colantoni A; De Maria N; Van Thiel DH
    J Viral Hepat; 1996 Nov; 3(6):333-40. PubMed ID: 8947886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B viral factors and treatment responses in chronic hepatitis B.
    Lin CL; Kao JH
    J Formos Med Assoc; 2013 Jun; 112(6):302-11. PubMed ID: 23787007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quantification of hepatitis B virus HBsAg: clinical implications].
    Buti M; Rodríguez Frías F; Esteban R
    Med Clin (Barc); 2012 Apr; 138(11):483-8. PubMed ID: 21719049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Analysis of Polyethylene Glycol Interferon-α Treatment in 155 Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) Patients.
    Luo X; Yu JX; Xie L; Ma WJ; Wang LH
    Ann Hepatol; 2017 November-December,; 16(6):888-892. PubMed ID: 29055925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peginterferon and lamivudine for hepatitis B.
    Assy NN; Hussein O
    N Engl J Med; 2004 Dec; 351(27):2879; author reply 2879. PubMed ID: 15625344
    [No Abstract]   [Full Text] [Related]  

  • 36. Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized Mice.
    Uchida T; Imamura M; Hayes CN; Hiraga N; Kan H; Tsuge M; Abe-Chayama H; Zhang Y; Makokha GN; Aikata H; Miki D; Ochi H; Ishida Y; Tateno C; Chayama K
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment.
    Ozaras R; Tabak F; Tahan V; Ozturk R; Akin H; Mert A; Senturk H
    Dig Dis Sci; 2008 Nov; 53(11):2995-8. PubMed ID: 18409002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B viral kinetics: a dynamic puzzle still to be resolved.
    Neumann AU
    Hepatology; 2005 Aug; 42(2):249-54. PubMed ID: 16025494
    [No Abstract]   [Full Text] [Related]  

  • 39. [Low-levels of HBsAg quantification at 48-week in HBeAg-negative chronic hepatitis B patients are the advantageous population for HBsAg clearance].
    Yan YJ; Wang XX; Cao ZH; Lu JF; Jin Y; He ZM; Geng N; Ren S; Ma LN; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):813-818. PubMed ID: 30616314
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B.
    Rossetti B; Bianco C; De Luca A
    Infection; 2012 Jun; 40(3):347-9. PubMed ID: 22002731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.